Walleye Capital’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40K	Sell	14,600 -161,700	-92%	-$512K	﹤0.01%	3950
2025 Q4	$652K	Buy	176,300 +156,200	+777%	+$505K	﹤0.01%	2770
2025 Q3	$53.3K	Buy	+20,100	New	+$38.9K	﹤0.01%	3985
2025 Q1	–	Sell	-18,900	Closed	-$41.6K	–	4476
2024 Q4	$41.6K	Buy	+18,900	New	+$44.1K	﹤0.01%	4400
2023 Q2	–	Sell	-500	Closed	-$795	–	4465
2023 Q1	$795	Buy	+500	New	+$2.58K	﹤0.01%	3840
2022 Q4	–	Sell	-13,800	Closed	-$92K	–	3306
2022 Q3	$92K	Buy	+13,800	New	+$94.8K	﹤0.01%	2453
2020 Q1	–	Sell	-23,600	Closed	-$1.41M	–	1148
2019 Q4	$1.41M	Sell	23,600 -16,500	-41%	-$742K	0.09%	303
2019 Q3	$1.47M	Buy	40,100 +38,800	+2,985%	+$1.54M	0.09%	313
2019 Q2	$60K	Sell	1,300 -12,500	-91%	-$587K	0.01%	1341
2019 Q1	$554K	Buy	+13,800	New	+$619K	0.09%	358